Ibandronate in osteoporosis: preclinical data and rationale for intermittent dosingBAUSS, Frieder; RUSSELL, R. Graham G.Osteoporosis international. 2004, Vol 15, Num 6, pp 423-433, issn 0937-941X, 11 p.Article

Osteoporosis treatment: why ibandronic acid?ROSSINI, Maurizio; ORSOLINI, Giovanni; ADAMI, Silvano et al.Expert opinion on pharmacotherapy. 2013, Vol 14, Num 10, pp 1371-1381, issn 1465-6566, 11 p.Article

Effects of ibandronate on bone quality : Preclinical studiesBAUSS, F; DEMPSTER, D. W.Bone (New York, NY). 2007, Vol 40, Num 2, pp 265-273, issn 8756-3282, 9 p.Article

Intravenous ibandronate in men with osteoporosis: An open pilot study over 2 yearsLAMY, O; SANDINI, L; PACHE, I et al.Journal of endocrinological investigation (Testo stampato). 2003, Vol 26, Num 8, pp 728-732, issn 0391-4097, 5 p.Article

Adherence With Intravenous Zoledronate and Intravenous Ibandronate in the United States Medicare PopulationCURTIS, Jeffrey R; HUIFENG YUN; MATTHEWS, Robert et al.Arthritis care and research. 2012, Vol 64, Num 7, pp 1054-1060, issn 0893-7524, 7 p.Article

Adverse cutaneous drug reactions to ibandronateWEBER, Isabelle; OLAIWAN, Amani; BONTE, Isabelle et al.EJD. European journal of dermatology. 2011, Vol 21, Num 4, pp 591-594, issn 1167-1122, 4 p.Article

Ibandronate : Pharmacology and preclinical studiesRUSSELL, R. G. G.Bone (New York, NY). 2006, Vol 38, Num 4, issn 8756-3282, S7-S12, SUP1Article

Ibandronate : Un nouveau bisphosphonate par voie orale = Ibandronate : a new oral bisphosphonateThe Medical letter on drugs and therapeutics (Edition française). 2005, Vol 27, Num 11, pp 55-56, issn 0253-8512, 2 p.Article

Oral versus intravenous ibandronic acid : a comparison of treatment options for metastatic bone diseaseMYSTAKIDOU, Kyriaki; STATHOPOULOU, Evangelia; PARPA, Efi et al.Journal of cancer research and clinical oncology. 2008, Vol 134, Num 12, pp 1303-1310, issn 0171-5216, 8 p.Article

Impact of oral ibandronate 150 mg once monthly on bone structure and density in post-menopausal osteoporosis or osteopenia derived from in vivo μCTBOCK, Oliver; BORST, Hendrikje; BELLER, Gisela et al.Bone (New York, NY). 2012, Vol 50, Num 1, pp 317-324, issn 8756-3282, 8 p.Article

Once-monthly oral ibandronate provides significant improvement in bone mineral density in postmenopausal women treated with glucocorticoids for inflammatory rheumatic diseases: a 12-month, randomized, double-blind, placebo-controlled trialHAKALA, M; KRÖGER, H; VALLEALA, H et al.Scandinavian journal of rheumatology. 2012, Vol 41, Num 4, pp 260-266, issn 0300-9742, 7 p.Article

Changes in bone remodelling and antifracture efficacy of intermittent bisphosphonate therapy : implications from clinical studies with ibandronatePAPAPOULOS, S. E; SCHIMMER, R. C.Postgraduate medical journal. 2008, Vol 84, Num 992, pp 307-312, issn 0032-5473, 6 p.Article

Ibandronate reduces skeletal morbidity in patients with breast cancer : IbandronateTRIPATHY, Debu; DIEL, Ingo; BODY, Jean-Jacques et al.Seminars in oncology. 2004, Vol 31, Num 5, pp 64-66, issn 0093-7754, 3 p., SUP10Article

Changes in biochemical markers and bone mass after withdrawal of ibandronate treatment : Prediction of bone mass changes during treatmentRAVN, P; CHRISTENSEN, J. O; BAUMANN, M et al.Bone (New York, NY). 1998, Vol 22, Num 5, pp 559-564, issn 8756-3282Article

Improved GI Tolerability with Monthly Ibandronate in Women Previously Using Weekly BisphosphonatesBINKLEY, Neil; MARTENS, Mark G; SILVERMAN, Stuart L et al.Southern medical journal (Birmingham, Ala. Print). 2009, Vol 102, Num 5, pp 486-492, issn 0038-4348, 7 p.Article

Effective doses of ibandronate do not influence the 3-year progression of aortic calcification in elderly osteoporotic womenTANKO, Laszlo B; GERONG QIN; ALEXANDERSEN, Peter et al.Osteoporosis international. 2005, Vol 16, Num 2, pp 184-190, issn 0937-941X, 7 p.Article

Monthly oral ibandronate is well tolerated and efficacious in postmenopausal women : Results from the monthly oral pilot studyREGINSTER, Jean-Yves; WILSON, Katie M; DUMONT, Etienne et al.The Journal of clinical endocrinology and metabolism. 2005, Vol 90, Num 9, pp 5018-5024, issn 0021-972X, 7 p.Article

The bisphosphonate ibandronate improves implant integration in osteopenic ovariectomized ratsKURTH, A. H. A; EBERHARDT, C; MÜLLER, S et al.Bone (New York, NY). 2005, Vol 37, Num 2, pp 204-210, issn 8756-3282, 7 p.Article

Intravenous ibandronate injections in postmenopausal women with osteoporosis : One-year results from the dosing intravenous administration studyDELMAS, Pierre D; ADAMI, Silvano; BOLOGNESE, Michael et al.Arthritis and rheumatism. 2006, Vol 54, Num 6, pp 1838-1846, issn 0004-3591, 9 p.Article

Once-monthly ibandronate for postmenopausal osteoporosis : Review of a new dosing regimenPYON, Eunice Y.Clinical therapeutics. 2006, Vol 28, Num 4, pp 475-490, issn 0149-2918, 16 p.Article

Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE studyDELMAS, P. D; RECKER, R. R; CHESNUT, C. H et al.Osteoporosis international. 2004, Vol 15, Num 10, pp 792-798, issn 0937-941X, 7 p.Article

Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosisRECKER, R; STAKKESTAD, J. A; CHESNUT, C. H et al.Bone (New York, NY). 2004, Vol 34, Num 5, pp 890-899, issn 8756-3282, 10 p.Article

Positive alterations of viscoelastic and geometric properties in ovariectomized rat femurs with concurrent administration of ibandronate and PTHXIAO YANG; MUTHUKUMARAN, Padmalosini; DASDE, Shamal et al.Bone (New York, NY). 2013, Vol 52, Num 1, pp 308-317, issn 8756-3282, 10 p.Article

Ibandronate does not reduce the anabolic effects of PTH in ovariectomized rat tibiae: A microarchitectural and mechanical studyXIAO YANG; YONG HOOW CHAN; MUTHUKUMARAN, Padmalosini et al.Bone (New York, NY). 2011, Vol 48, Num 5, pp 1154-1163, issn 8756-3282, 10 p.Article

Renal tolerability of intermittent intravenous ibandronate treatment for patients with postmenopausal osteoporosis : a reviewMILLER, P. D; WARD, P; PFISTER, T et al.Clinical and experimental rheumatology (Testo stampato). 2008, Vol 26, Num 6, pp 1125-1133, issn 0392-856X, 9 p.Article